Literature DB >> 9223417

Limited proteolysis of human kidney angiotensin-converting enzyme and generation of catalytically active N- and C-terminal domains.

E D Sturrock1, S M Danilov, J F Riordan.   

Abstract

The somatic form of angiotensin converting enzyme is a class I ectoenzyme that is bound to the surface of endothelial calls. It consists of two homologous, catalytic domains of approximately 600 residues each; a juxtamembrane "stalk" region; a transmembrane, hydrophobic sequence; and a 30 residue, C-terminal cytosolic domain. We have used limited proteolysis to probe the structural and functional properties of the enzyme. Endoproteinase Asp-N cleaves both the Thr615-Asp616 and the Leu1219-Asp1220 peptide bonds to generate the two catalytic domains which were isolated by a combination of immunoaffinity and lisinopril Sepharose affinity chromatography. The enzymatic characteristics of the N and C fragments were examined with angiotensin I, hippuryl-His-Leu, and luteinizing hormone-releasing hormone and indicate that both fragments contain catalytically active sites that retain their individual functional integrity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223417     DOI: 10.1006/bbrc.1997.6841

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity.

Authors:  Zenda L Woodman; Sylva L U Schwager; Pierre Redelinghuys; Adriana K Carmona; Mario R W Ehlers; Edward D Sturrock
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

Review 2.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

3.  Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide.

Authors:  Mohd Akif; Sylva L Schwager; Colin S Anthony; Bertrand Czarny; Fabrice Beau; Vincent Dive; Edward D Sturrock; K Ravi Acharya
Journal:  Biochem J       Date:  2011-05-15       Impact factor: 3.857

4.  ACE for all - a molecular perspective.

Authors:  Charlotte Harrison; K Ravi Acharya
Journal:  J Cell Commun Signal       Date:  2014-07-16       Impact factor: 5.782

5.  A new high-resolution crystal structure of the Drosophila melanogaster angiotensin converting enzyme homologue, AnCE.

Authors:  Charlotte Harrison; K Ravi Acharya
Journal:  FEBS Open Bio       Date:  2015-08-11       Impact factor: 2.693

6.  Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme.

Authors:  Geoffrey Masuyer; Mohd Akif; Bertrand Czarny; Fabrice Beau; Sylva L U Schwager; Edward D Sturrock; R Elwyn Isaac; Vincent Dive; K Ravi Acharya
Journal:  FEBS J       Date:  2013-12-24       Impact factor: 5.542

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.